overall survival 3-year [clinicaltrials_resource:1aab8f5b6808998cc55afb69b2261ca6]
FOLFOX:
oxaliplatin 130mg/m2 on day 1, CF 400mg/m2 on day 1, 5-Fu 400mg/m2 on day 1; 5-FU 2400 mg/m2 46hr civ regimen repeated every 3 weeks Pre-operative chemotherapy: 2-4 cycles and peri-operative chemotherapy consist of 6 cycles
SOX:
oxaliplatin 130mg/m2 on day 1, S-1 for 14 days regimen repeated every 3 weeks Pre-chemotherapy: 2-4 cycles, totally 6 cycles of perioperative chemotherapy
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
overall survival 3-year [clinicaltrials_resource:1aab8f5b6808998cc55afb69b2261ca6]
FOLFOX:
oxaliplatin 130mg/m2 on day 1, CF 400mg/m2 on day 1, 5-Fu 400mg/m2 on day 1; 5-FU 2400 mg/m2 46hr civ regimen repeated every 3 weeks Pre-operative chemotherapy: 2-4 cycles and peri-operative chemotherapy consist of 6 cycles
SOX:
oxaliplatin 130mg/m2 on day 1, S-1 for 14 days regimen repeated every 3 weeks Pre-chemotherapy: 2-4 cycles, totally 6 cycles of perioperative chemotherapy
Bio2RDF identifier
1aab8f5b6808998cc55afb69b2261ca6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1aab8f5b6808998cc55afb69b2261ca6
measure [clinicaltrials_vocabulary:measure]
overall survival
time frame [clinicaltrials_vocabulary:time-frame]
description
FOLFOX:
oxaliplatin 130mg/m2 o ...... of perioperative chemotherapy
identifier
clinicaltrials_resource:1aab8f5b6808998cc55afb69b2261ca6
title
overall survival 3-year
@en
type
label
overall survival 3-year [clinicaltrials_resource:1aab8f5b6808998cc55afb69b2261ca6]
@en